Immunovant, Inc. IMVT Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s common stock?
- Immunovant, Inc. (IMVT) reported common stock of $20K in Q1 2026.
- How has Immunovant, Inc.'s common stock changed year-over-year?
- Immunovant, Inc.'s common stock increased by 25.0% year-over-year, from $16K to $20K.
- What is the long-term trend for Immunovant, Inc.'s common stock?
- Over 5 years (2021 to 2026), Immunovant, Inc.'s common stock has grown at a 14.9% compound annual growth rate (CAGR), from $10K to $20K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).